{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:55:59Z","timestamp":1781614559580,"version":"3.54.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jpha.2025.101498","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:45:31Z","timestamp":1764089131000},"page":"101498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNA-encoded library screening identifies CDK2-targeting lead compounds with favorable drug-like properties for anticancer development"],"prefix":"10.1016","volume":"16","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0876-0050","authenticated-orcid":false,"given":"Sheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-3606","authenticated-orcid":false,"given":"Jianzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101498_bib1","doi-asserted-by":"crossref","first-page":"101173","DOI":"10.1016\/j.jpha.2024.101173","article-title":"New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy","volume":"15","author":"Dai","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpha.2025.101498_bib2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.21037\/tcr-22-2807","article-title":"A narrative review about CDK4\/6 inhibitors in the setting of drug resistance: updates on biomarkers and therapeutic strategies in breast cancer","volume":"12","author":"Zhao","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101498_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000484167","article-title":"Mechanisms of resistance to CDK4\/6 inhibitors in breast cancer and potential biomarkers of response","volume":"12","author":"Guarducci","year":"2017","journal-title":"Breast Care"},{"key":"10.1016\/j.jpha.2025.101498_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","article-title":"Targeting CDK2 in cancer: challenges and opportunities for therapy","volume":"25","author":"Tadesse","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpha.2025.101498_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/13543776.2022.2078193","article-title":"A patent review of anticancer CDK2 inhibitors (2017\u2013present)","volume":"32","author":"Said","year":"2022","journal-title":"Expert Opin. Ther. Pat."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:08:35Z","timestamp":1781611715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925003156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2095177925003156"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101498","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA-encoded library screening identifies CDK2-targeting lead compounds with favorable drug-like properties for anticancer development","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101498"}}